Adverse events related to the use of embryo transfer catheters (ETCs) may be underreported to the US Food and Drug Administration (FDA), according to a new study presented at the 2023 annual meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback